QINLOCK 50MG- 90s (Ripretinib Tablet) 50mg

Qinlock 50mg tablets are prescribed for gastrointestinal stromal tumors and advanced solid tumors. This targeted therapy helps manage disease progression with a convenient oral form. Store below 25°C and keep out of reach of children. Always follow healthcare provider guidance when using Qinlock 50mg.

Strength

50mg

Pack Size

90s

Storage

Below 25°C

Manufacturer / TM Owner

Specialised Therapeutics Pharma Pty Ltd

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Qinlock 50mg tablets are used to treat gastrointestinal stromal tumors (GIST) and other advanced solid tumors. Patients with unresectable or metastatic conditions may benefit from this targeted therapy. It is designed for adults who require systemic treatment under medical supervision.

Side Effects

Qinlock 50mg tablets work by targeting specific pathways in tumor cells to slow disease progression. Common effects may include mild fatigue, nausea, or skin reactions. Some patients report digestive discomfort or changes in appetite during treatment.

Precautions & Warnings

Keep Qinlock 50mg tablets in their original packaging and store below 25°C. Avoid exposure to moisture or direct sunlight. Do not crush, split, or chew the tablets unless advised by a healthcare professional. Report any unusual symptoms to your doctor promptly.

Avoid Interactions

Qinlock 50mg may interact with strong CYP3A inhibitors or inducers, altering its effectiveness. Avoid grapefruit products and St. John’s wort during treatment. Discuss all medications, including over-the-counter drugs, with your healthcare provider before starting Qinlock.

Frequently Asked Questions

Qinlock 50mg is used to treat gastrointestinal stromal tumors (GIST) and other advanced solid tumors in adults.

Store Qinlock 50mg tablets below 25°C in their original packaging and away from moisture or sunlight.

Do not crush, split, or chew Qinlock 50mg tablets unless instructed by your healthcare provider.

Common effects may include fatigue, nausea, skin reactions, or digestive discomfort.

Yes, it may interact with CYP3A inhibitors or inducers; consult your doctor before combining with other drugs.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.